Skip to content

The TransEnterix Global Patient Registry for Robotic assisted Laparoscopic Procedures in Urology, Abdominal Surgery, Thoracic and Gynecolocic Surgery

The TransEnterix Global Patient Registry for Robotic assisted Laparoscopic Procedures in Urology, Abdominal Surgery, Thoracic and Gynecolocic Surgery - TRUST 01

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013461
Enrollment
15000
Registered
2017-12-08
Start date
2018-01-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple abdominal, thoracic, urological and gynecological surgeries

Interventions

Group 1: Adult patients with an indication for laparoscopic or thoracoscopic surgical intervention in urology, abdominal surgery, thoracic surgery or gynecology using the Senhance Surgical Robot Syste

Sponsors

TransEnteric Inc.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - indication for laparoscopic or thoracoscopic surgical intervention which by the discretion of the treating surgeon is to be performed using the Senhance Surgical Robot System - for retrospective data collection: adult patients who have been treated with the support of the Senhance Surgical Robot System and that have agreed to provide their data according to the patient's informed consent - signed and dated patient informed consent

Exclusion criteria

Exclusion criteria: - patients with any contraindication for a laparoscopic / thorascopic surgical procedure - life-threatening disease, which in the investigator's opinion limits the subjects life expectancy to less than 12 months - patient's inability to give informed consent; for example, through disability, inadequate skills of the German language or dementia

Design outcomes

Primary

MeasureTime frame
Safety, assessed by the incidence and severity of adverse events acutely and through 12-months follow-up.

Secondary

MeasureTime frame
Efficacy, evaluated based on data indicating procedural success, deviations from the planned surgical course including conversions during the procedure to standard laparoscopic surgery, or open surgery. Procedural efficacy will be evaluated using various surgical measures and procedural measures. Patient reported outcomes include pain scores and quality of life. Surgical workload of the operating surgeon will be assessed by questionnaire.

Countries

Austria, Belarus, Croatia, Germany, Lithuania

Contacts

Public ContactFrank Willeke

St. Marien-Krankenhaus Siegen gem GmbH Chirurgische Klinik

f.willeke@marienkrankenhaus.com0271 231 1502

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026